X0202 SCHEDULE 13G 0001693149 XXXXXXXX LIVE Common Stock, par value $0.0001 03/31/2026 0001696556 Once Upon a Farm, PBC 68237F108 950 Gilman Street, Suite 100 Berkeley CA 94710 Rule 13d-1(d) CAVU Venture Partners II, LP b DE 7411502 0 7411502 0 7411502 N 17.7 PN CAVU Venture Partners III, LP b DE 2274219 0 2274219 0 2274219 N 5.4 PN CAVU Venture Partners IV L.P. b DE 731396 0 731396 0 731396 N 1.7 PN TNG Investors LP / DE b DE 646478 0 646478 0 646478 N 1.5 PN Once Upon a Farm, PBC 950 Gilman Street, Suite 100, Berkeley, CA 94710 This statement is being filed by CAVU Venture Partners II L.P. ("CAVU II"), CAVU Venture Partners III L.P. ("CAVU III"), CAVU Venture Partners IV L.P. ("CAVU IV") and TNG Investors LP ("TNG" and together with CAVU II, CAVU III and CAVU IV, the "Reporting Persons"). The address of the principal business and principal office of each of the Reporting Persons is 515 West 20th Street, Suite 4W, New York, NY 10011. Each of the Reporting Persons is incorporated under the laws of Delaware. Y (1) Fund II directly owns 7,411,502 shares of Common Stock, representing approximately 17.7% of the outstanding Common Stock. (2) Fund III directly owns 2,274,219 shares of Common Stock, representing approximately 5.4% of the outstanding Common Stock. (3) Fund IV directly owns 731,396 shares of Common Stock, representing approximately 1.7% of the outstanding Common Stock. (4) TNG directly owns 646,478 shares of Common Stock, representing approximately 1.5% of the outstanding Common Stock. CAVU Venture Partners GP II, LP ("Fund II GP"), as the general partner of Fund II, and CAVU Venture Partners GP II, LLC ("Fund II GP LLC"), as the general partner of Fund II GP, each may be deemed to beneficially own the shares of Common Stock held directly by Fund II. CAVU Venture Partners GP III, LP ("Fund III GP"), as the general partner of Fund III, and CAVU Venture Partners GP III, LLC ("Fund III GP LLC"), as the general partner of Fund III GP, each may be deemed to beneficially own the shares of Common Stock held directly by Fund III. CAVU Venture Partners GP IV, LP ("Fund IV GP"), as the general partner of Fund IV and TNG, and CAVU Venture Partners GP IV, LLC ("Fund IV GP LLC"), as the general partner of Fund IV GP, each may be deemed to beneficially own the shares of Common Stock held directly by Fund IV and TNG. See responses in Item 4(a) above. The percent of class was based upon 41,881,392 shares of Common Stock outstanding as of March 6, 2026, as reported by the Issuer in its Annual Report on Form 10-K filed on March 16, 2026. (1) Fund II: 7,411,502 shares of Common Stock. (2) Fund III: 2,274,219 shares of Common Stock. (3) Fund IV: 731,396 shares of Common Stock. (4) TNG: 646,478 shares of Common Stock. 0 (1) Fund II: 7,411,502 shares of Common Stock. (2) Fund III: 2,274,219 shares of Common Stock. (3) Fund IV: 731,396 shares of Common Stock. (4) TNG: 646,478 shares of Common Stock. 0 Y Y Y Y Y Y CAVU Venture Partners II, LP /s/ Brett Thomas 05/15/2026 CAVU Venture Partners III, LP /s/ Brett Thomas 05/15/2026 CAVU Venture Partners IV L.P. /s/ Brett Thomas 05/15/2026 TNG Investors LP / DE /s/ Brett Thomas 05/15/2026